HUMAN OSTEOARTHRITIC CHONDROCYTES POSSESS AN INCREASED NUMBER OF INSULIN-LIKE GROWTH-FACTOR 1 BINDING-SITES BUT ARE UNRESPONSIVE TO ITS STIMULATION - POSSIBLE ROLE OF IGF-1-BINDING PROTEINS
S. Dore et al., HUMAN OSTEOARTHRITIC CHONDROCYTES POSSESS AN INCREASED NUMBER OF INSULIN-LIKE GROWTH-FACTOR 1 BINDING-SITES BUT ARE UNRESPONSIVE TO ITS STIMULATION - POSSIBLE ROLE OF IGF-1-BINDING PROTEINS, Arthritis and rheumatism, 37(2), 1994, pp. 253-263
Objective. To characterize the insulin-like growth factor 1 (IGF-1) re
ceptor in human osteoarthritic (OA) and normal adult chondrocytes. The
biologic response of chondrocytes to IGF-1 stimulation was examined,
as was the presence and synthesis of IGF binding proteins (IGFBP) in t
hese cells. Methods. Binding studies, Northern blot, immunohistochemic
al analysis, and affinity cross-linking experiments were performed for
characterization of the IGF receptor, and the latter method was also
used for IGFBB determination. The biologic response was estimated via
the incorporation of radiolabeled proline into a newly synthesized pro
tein. Results. Binding experiments revealed a single class of binding
sites. The mean +/- SEM affinity (K-d) of normal chondrocytes was 1.4
+/- 0.4 nM, with 26.8 +/- 5.5 x 10(3) binding sites/cell. OA chondrocy
tes had a lower affinity (K-d 15.4 +/- 4.7 nM) and a higher density (1
,178.3 +/- 299.5 x 10(3) binding sites/cell) compared with normal cell
s (P < 0.004 and P < 0.001, respectively). Immune-histochemical studie
s with a monoclonal antibody (MAb) against the type 1 IGF receptor (al
pha IR3) showed increased staining in OA cartilage compared with norma
l tissue. Biologic responses of chondrocytes after IGF-1 stimulation r
evealed that OA chondrocytes were unresponsive, whereas a 2.5-fold inc
rease in new protein synthesis was observed in normal cells. Competiti
on studies in normal chondrocytes revealed that both IGF-1 and IGF-2 d
isplaced radiolabeled IGF-1 in a comparable manner; however, insulin a
t high concentration weakly competes. Moreover, MAb alpha IR3 effectiv
ely blocked specific binding in normal chondrocytes (77%), but not in
OA chondrocytes (26%). Northern blot and covalent cross-linking analys
es revealed the specific band characteristic of type 1 receptor. With
the latter technique, other bands corresponding to the IGFBPs were als
o detected. Comparison between normal and OA chondrocytes showed incre
ased intensity of the IGFBP bands, particularly those corresponding to
the IGFBP-3 doublet. Conclusion. It is shown that type 1 IGF receptor
is expressed in human articular cartilage and that tbe level of bindi
ng sites is significantly increased in OA chondrocytes. Interestingly,
despite the higher level of binding sites in OA cells, no response to
IGF-1 stimulation was found in these cells. Our data suggest that thi
s increase in specific binding may involve not only the type 1 IGF rec
eptor but also IGFBP on the cell surface. The latter, by binding the I
GF-1, will diminish the bioavailability of IGF-1 and thus prevent its
anabolic action.